Search

Your search keyword '"Trajkovic-Arsic, Marija"' showing total 243 results

Search Constraints

Start Over You searched for: Author "Trajkovic-Arsic, Marija" Remove constraint Author: "Trajkovic-Arsic, Marija"
243 results on '"Trajkovic-Arsic, Marija"'

Search Results

1. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer

2. Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularization

3. Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation

5. Histology-Based Radiomics for [18F]FDG PET Identifies Tissue Heterogeneity in Pancreatic Cancer

6. Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma

7. Fibroblast Activation Protein-Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial.

9. Development of a LRRC15-Targeted Radio-Immunotheranostic Approach to Deplete Pro-tumorigenic Mechanisms and Immunotherapy Resistance

10. Minimally invasive determination of PDAC subtype and therapy-induced subtype switch by means of circulating cell-free RNA

11. MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I

12. Author Correction: Hyperpolarized 13C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC

13. Hyperpolarized 13C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC

15. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma

16. The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma

18. Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma

20. Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy

21. Superior Tumor Detection for68Ga-FAPI-46 Versus18F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma

22. Figure S3 from LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth

23. Supplementary Data DS1 from LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth

24. Supplement from Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer

25. Data from Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting

26. Figure S2 from Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting

30. Dose‐dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::AF9‐induced leukaemic cells.

32. LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth

33. Additional file 1 of Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma

34. Additional file 2 of Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma

35. Superior Tumor Detection for 68Ga-FAPI-46 Versus 18F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma.

36. Functional non-invasive detection of glycolytic pancreatic ductal adenocarcinoma

38. Epigenetic plasticity via adaptive DNA hypermethylation and clonal expansion underlie resistance to oncogenic pathway inhibition in pancreatic cancer

39. EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis

41. N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma

42. 3112 – GROWTH FACTOR INDEPENDENCE 1 EXPRESSION INDUCED METABOLIC VULNERABILITIES AND PRESENTS NOVEL THERAPEUTIC OPPORTUNITIES IN ACUTE MYELOID LEUKAEMIA

43. Functional metabolic phenotyping of human pancreatic ductal adenocarcinoma

44. Is metabolism the magic bullet for targeted cancer therapy?

45. Hyperpolarized ¹³C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC

46. Hyperpolarized ¹³C spectroscopy with simple slice-and-frequency-selective excitation

47. Additional file 2 of Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic ductal adenocarcinoma

48. Author Correction: Hyperpolarized ¹³C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC

49. Additional file 1 of Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic ductal adenocarcinoma

50. Additional file 3 of Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic ductal adenocarcinoma

Catalog

Books, media, physical & digital resources